User profiles for Steve Gallinger
 | Steven GallingerProfessor of Surgery, University of Toronto Verified email at utoronto.ca Cited by 102124 |
[PDF][PDF] Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors
…, MA Barker, JR Jass, J Hopper, S Gallinger… - Journal of clinical …, 2002 - seom.org
Purpose: To compare microsatellite instability (MSI) testing with immunohistochemical (IHC)
detection of hMLH1 and hMSH2 in colorectal cancer. Patients and Methods: Colorectal …
detection of hMLH1 and hMSH2 in colorectal cancer. Patients and Methods: Colorectal …
Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell–and patient-derived tumor organoids
There are few in vitro models of exocrine pancreas development and primary human pancreatic
adenocarcinoma (PDAC). We establish three-dimensional culture conditions to induce …
adenocarcinoma (PDAC). We establish three-dimensional culture conditions to induce …
Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X
…, GM Petersen, R Haile, G Casey, J Baron, S Gallinger… - Jama, 2005 - jamanetwork.com
ContextApproximately 60% of families that meet the Amsterdam-I criteria (AC-I) for
hereditary nonpolyposis colorectal cancer (HNPCC) have a hereditary abnormality in a DNA …
hereditary nonpolyposis colorectal cancer (HNPCC) have a hereditary abnormality in a DNA …
Risks of Lynch Syndrome Cancers for MSH6 Mutation Carriers
…, L Le Marchand, R Haile, S Gallinger… - Journal of the …, 2010 - academic.oup.com
Background Germline mutations in MSH6 account for 10%–20% of Lynch syndrome colorectal
cancers caused by hereditary DNA mismatch repair gene mutations. Because there have …
cancers caused by hereditary DNA mismatch repair gene mutations. Because there have …
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
CA O'Brien, A Pollett, S Gallinger, JE Dick - Nature, 2007 - nature.com
Colon cancer is one of the best-understood neoplasms from a genetic perspective 1 , 2 , 3 ,
yet it remains the second most common cause of cancer-related death, indicating that some …
yet it remains the second most common cause of cancer-related death, indicating that some …
[PDF][PDF] Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of …
…, J Hamm, A Figer, JR Hecht, S Gallinger… - Journal of clinical …, 2007 - Citeseer
Purpose Patients with advanced pancreatic cancer have a poor prognosis and there have
been no improvements in survival since the introduction of gemcitabine in 1996. Pancreatic …
been no improvements in survival since the introduction of gemcitabine in 1996. Pancreatic …
[HTML][HTML] Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer
…, D Tu, M Redston, S Gallinger - … England Journal of …, 2003 - Mass Medical Soc
Background Colon cancers with high-frequency microsatellite instability have clinical and
pathological features that distinguish them from microsatellite-stable tumors. We investigated …
pathological features that distinguish them from microsatellite-stable tumors. We investigated …
Colon Cancer Family Registry: an international resource for studies of the genetic epidemiology of colon cancer
PA Newcomb, J Baron, M Cotterchio, S Gallinger… - … Biomarkers & Prevention, 2007 - AACR
Background: Family studies have served as a cornerstone of genetic research on colorectal
cancer. Materials and Methods: The Colorectal Cancer Family Registry (Colon CFR) is an …
cancer. Materials and Methods: The Colorectal Cancer Family Registry (Colon CFR) is an …
Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries
Colorectal cancer (CRC) is a leading cause of mortality worldwide. We conducted a genome-wide
association study meta-analysis of 100,204 CRC cases and 154,587 controls of …
association study meta-analysis of 100,204 CRC cases and 154,587 controls of …
[HTML][HTML] Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer
…, JF Seitz, F Sinicrope, S Gallinger - Journal of clinical …, 2010 - ncbi.nlm.nih.gov
Purpose Prior reports have indicated that patients with colon cancer who demonstrate high-level
microsatellite instability (MSI-H) or defective DNA mismatch repair (dMMR) have …
microsatellite instability (MSI-H) or defective DNA mismatch repair (dMMR) have …